Figure 5
Differential cytokine receptor expression, IL-15–mediated proliferation, and caspase activity of TCM/Eand TEM/E. (A) IL-15Rα, IL-2Rβ, or IL-2Rγ expression by TCM/E and TEM/E. Mean fluorescence intensity was normalized to that of isotype control staining in each case to determine ΔMFI. (B) Proliferation of TCM/E and TEM/E was determined after 48-hour incubation with different concentrations of rhIL-15 using a standard [3H]-thymidine incorporation assay. (C-D) CFSE-labeled TCM/E and TEM/E (107) were injected intravenously into mice at day 0, and irradiated NS0-IL-15 cells (1.5 × 107) were administered 3 times a week starting at day 0, until mice were killed at either day 9 or day 12. (C) CFSE profiles of the input and engrafted TCM/E and TEM/E in day 9 PBL was assessed by flow cytometry. Percentage of CFSE-diluted cells that fall within the first log are indicated. (D) Engraftment of the CD45+ human T cells in the PBL, bone marrow, and spleen was assessed on days 9 and 12 by flow cytometry. (E) FL-1 profiles of CD45+ human T cells in the PBL were assessed on day 9 as a readout for cleavage of the caspase substrate D2R. The percentage of cells with cleaved D2R is depicted.

Differential cytokine receptor expression, IL-15–mediated proliferation, and caspase activity of TCM/Eand TEM/E. (A) IL-15Rα, IL-2Rβ, or IL-2Rγ expression by TCM/E and TEM/E. Mean fluorescence intensity was normalized to that of isotype control staining in each case to determine ΔMFI. (B) Proliferation of TCM/E and TEM/E was determined after 48-hour incubation with different concentrations of rhIL-15 using a standard [3H]-thymidine incorporation assay. (C-D) CFSE-labeled TCM/E and TEM/E (107) were injected intravenously into mice at day 0, and irradiated NS0-IL-15 cells (1.5 × 107) were administered 3 times a week starting at day 0, until mice were killed at either day 9 or day 12. (C) CFSE profiles of the input and engrafted TCM/E and TEM/E in day 9 PBL was assessed by flow cytometry. Percentage of CFSE-diluted cells that fall within the first log are indicated. (D) Engraftment of the CD45+ human T cells in the PBL, bone marrow, and spleen was assessed on days 9 and 12 by flow cytometry. (E) FL-1 profiles of CD45+ human T cells in the PBL were assessed on day 9 as a readout for cleavage of the caspase substrate D2R. The percentage of cells with cleaved D2R is depicted.

Close Modal

or Create an Account

Close Modal
Close Modal